Articles by Edgar Olivas, MD

¿Qué sucede cuando los anticuerpos biespecíficos dejan de funcionar en el mieloma múltiple: cuatro estrategias para superar la resistencia?

What Happens When Bispecific Antibodies Stop Working in Multiple Myeloma: Four Strategies to Overcome Resistance

A New Genomic Definition of High-Risk Myeloma, Validated in Thousands of Patients

Is a Cure Finally on the Table? The Leading Myeloma Specialists Update the Conversation

Why Multiple Myeloma Can Return After CAR T-Cell Therapy

New Myeloma Response Criteria: What's Changing in How Doctors Measure Treatment Success

How Blood-Based Liquid Biopsies Could Transform Multiple Myeloma Monitoring